玉米MON 810旨在通过引入硫化硫酸芽孢杆菌基因的一部分来编码杀虫性的Cry1ab蛋白。Following the submission of applications EFSA-GMO-RX-MON810 and EFSA-GMO- NL-2012-107, and the publication of the EFSA scientific opinions 45 , the placing on the market of maize MON 810 for food and feed uses (including pollen), excluding cultivation in the EU, was authorised by Commission Implementing Decisions 2013/649/EU and 2017/1207/EU。2022年,申请人要求欧洲委员会更新授权在玉米市场810的市场上,并提交了Dossier GMFF-2022-9450,以支持其请求。GMO小组根据第1829/2003号法规第11和23条评估了该申请,以及相关的EFSA指南。GMO小组修改了意见草案,并在适当的情况下提出并在各个部分提出了问题。GMO小组采用了该意见,该意见将在EFSA网站和EFSA杂志上发表。